Clinical trial
Intravitreal Bevacizumab for Polypoidal Choroidal Vasculopathy
NCT00383812 · Asan Medical Center, Other · Unknown status
Key facts
| NCT number | NCT00383812 |
|---|---|
| Title | Intravitreal Bevacizumab for Polypoidal Choroidal Vasculopathy |
| Official title | Intravitreal Bevacizumab for Polypoidal Choroidal Vasculopathy |
| Lead sponsor | Asan Medical Center, Other |
| Status | Unknown status |
| Study type | Interventional |
| Conditions | Polypoidal Choroidal Vasculopathy |
| Intervention type | Drug |
| Interventions | Intravitreal Bevacizumab |
| Enrollment | 20 |
| Start date | May 1, 2006 |
| Completion | May 1, 2008 |
| First posted | Oct 4, 2006 |
| Last update posted | Oct 4, 2006 |
| Countries | South Korea |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 FDA inspections linked to this trial
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: